TSHβX1 and D2 THR92ALA in Pregnancy

NCT03612908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2018-08-02

No results posted yet for this study

Summary

Thyroid diseases are pathologies that frequently affect pregnant women causing serious complications. This current research aims to find out whether the expression of TSHβX1 splice variant and D2 Thr92Ala polymorphism in the DIO2 gene are associated with thyroid disease in Mexican pregnant women.

Conditions

Sponsors & Collaborators

  • Universidad Autonoma del Estado de Mexico

    collaborator OTHER
  • Ciprés Grupo Médico CGM SC

    collaborator OTHER
  • Materno-Perinatal Hospital of the State of Mexico

    lead OTHER

Principal Investigators

  • Mendieta Zerón · Hospital Materno-Perinatal "Mónica Pretelini Sáenz".

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2017-12-15
Completion
2018-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03612908 on ClinicalTrials.gov